@FiercePharma: Top-read on FP this weekend: Pfizer faces growing legal threat over Lipitor. Article | Follow @FiercePharma
@EricPFierce: ICYMI last week: Instead of buying counterfeit Viagra from China, this guy bought APIs and whipped up an ED drug in his home lab. More | Follow @EricPFierce
@CarlyHFierce: Favorite fact I've learned so far today: The inhaler for MannKind's Afrezza inhaler is named "Dreamboat." | Follow @CarlyHFierce
> The FDA has approved Johnson & Johnson's ($JNJ) Invokamet, a combination of its diabetes drug Invokana and metformin. Story
> Vax leader GlaxoSmithKline ($GSK) says it will soon start a clinical trial for a vaccine for the lethal Ebola virus. Story
> Cubist Pharmaceuticals ($CBST) has expanded its recall of anti-infection drug Cubicin to 9 lots because of particulate matter found in some vials. Release
> Gregg Gonsalves, who was a big critic of the FDA in the 1990s in his fight for drugs to treat AIDS, is now defending the agency against what he considers anti-regulatory sentiment. Story
Medical Device News
@FierceMedDev: ICYMI: Volcano guides lower but offers long-term vision, Wall Street trims by as much as 25%. Article | Follow @FierceMedDev
@StacyALawrence: Med tech M&A gets much, much bigger during the first half. Feature | Follow @StacyALawrence
@VarunSaxena2: RT @foodanddruglaw: CMS delays launch of Sunshine Act reporting website. More from The Hill | Follow @VarunSaxena2
@MichaelGFierce: Carnegie Mellon team creates self-assembling nanofibers for shaped delivery vehicles. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: Not for the faint of heart: A behind-the-scenes look at creating prosthetic eyes. More from NPR | Follow @EmilyWFierce
> Medtronic hires former senators to lobby against anti-inversion bill and protect acquisition of Covidien. Report
> Imaging pen may detect skin cancer faster. More
Biotech News
@FierceBiotech: Can GlaxoSmithKline go from 0 to 150 on an Ebola vaccine program? Story | Follow @FierceBiotech
@JohnCFierce: ICYMI last week: How big is Novartis's LCZ696 heart drug? Experts bet on a key number. More | Follow @JohnCFierce
@DamianFierce: $MNKD finally gets its Afrezza deal as $SNY signs up for $150M up front and $775M in milestones. Article | Follow @DamianFierce
> Forward Pharma sets sights on Biogen with a $200M IPO. Article
> J&J's diabetes combo wins FDA nod in a fast-crowding space. News
> Google sheds glancing light on Calico, its anti-aging biotech. More
CRO News
> Icon charts another sales jump with eyes on a big year. Report
> Charles River's checkbook fuels a leap in revenue. More
> Quintiles and Roche take to China with testing partnership. News
> Parexel notches double-digit annual growth with a big year ahead. Article
> Deal-minded Venn buys another CRO. Story
Biotech IT News
> Actelion working with PatientsLikeMe rare cancer community on outcome measure. Report
> U.S. research institutes target standard neuroscience data format. More
> AllSeq, DNAnexus share data from Illumina HiSeq X Ten. Story
> Google rolls out preview of healthcare app development kit. Article
> The race to build a robo-chemist. Item
Animal Health News
> Cost spike of doxycycline has created sticker shock for pet owners. Report
> Zoetis CEO sees global factors coalescing to spur more growth. More
> Medical marijuana coming to the pet med market. Item
> SmartPak acquisition helps Henry Schein grow its animal health sales. Story
> Zoetis expects to have PEDv vaccine ready this year. Article
And Finally... The fight over the price Pfizer ($PFE) can charge in India for its popular cough syrup Benadryl continues. Report